New Member Proposed for Swedish Match Board of Directors

  New Member Proposed for Swedish Match Board of Directors

Business Wire

STOCKHOLM -- March 11, 2013

Regulatory News:

At the upcoming Annual General Meeting on April 25, 2013, the Nominating
Committee of Swedish Match AB (STO:SWMA)will propose the election of Wenche
Rolfsen as a new member of the Swedish Match Board of Directors.

Wenche Rolfsen has broad experience from development, marketing and sales of
products within health care and consumer products.

Wenche Rolfsen is currently the Chairman of the Boards of Aprea AB, a Swedish
biotech company, and of Index Pharmaceuticals, a Swedish pharmaceutical
company. She is also the Vice Chairman of Moberg Derma, a Swedish
pharmaceutical company listed on the NASDAQ OMX Stockholm and board member of
Stiftelsen Industrifonden amongst others.

Wenche Rolfsen has a long experience of non-executive Board assignments from
private and public companies in Sweden, Norway and in the UK. Previous Board
assignments include AkerBiomarine AS, Axis Shield Diagnostics Plc, Bionor
Pharma AS and Swedish Orphan Biovitrum AB.

Wenche Rolfsen holds a Master of Science in Pharmacy and a Ph.D in
pharmacology (1980) from the Pharmaceutical Faculty of Uppsala University. For
a number of years she held an adjunct professorship in Pharmacology at the
same university.

Wenche Rolfsen has previously held several executive positions within the
Pharmacia Corporation and in Quintiles Transnational, a global company in
pharmaceutical services.

The Nominating Committee has made particular note of Rolfsen’s knowledge of
the Norwegian market as well as her broad experience with development and
commercialization of highly regulated products within the health care and
consumer products sectors in different parts of the world.

Consequently, the Nominating Committee will propose re-election of the present
Board members Conny Karlsson, Andrew Cripps, Karen Guerra, Robert F. Sharpe,
Meg Tivéus and Joakim Westh. New election is proposed of Wenche Rolfsen. The
Nominating Committee will propose Conny Karlsson as the Chairman of the Board
and Andrew Cripps as the deputy Chairman of the Board.

The Nominating Committee in Swedish Match AB consists of Conny Karlsson
(Chairman of the Board), Andy Brown (Cedar Rock Capital), Björn Lind (AMF &
AMF Funds), William Lock (Morgan Stanley Investment Management), and William
von Mueffling (Cantillon Capital Management). Andy Brown is the Chairman of
the Committee.

The character of this information is such that it shall be disclosed by
Swedish Match AB (publ) in accordance with the Swedish Securities Markets Act.
The information was disclosed to the media on 11 March 2013 11.00 a.m. (CET).

Swedish Match develops, manufactures, and sells market-leading brands in the
product areas Snus and snuff, Other tobacco products (US mass market cigars
and chewing tobacco), and Lights (matches and lighters). Well known brands
include General snus, Longhorn moist snuff, Red Man chewing tobacco, White Owl
cigars, Cricket lighters, and Fiat Lux matches. The Group sells products
across the globe, with production units in six countries. The Group’s global
operations generated sales of 12,486 MSEK for the twelve month period ending
December 31, 2012. The Swedish Match share is listed on the NASDAQ OMX
Stockholm (SWMA).

This information was brought to you by Cision


Swedish Match AB (publ)
Lars Dahlgren
President and Chief Executive Officer
Office +46 8 658 0441
Joakim Tilly
Chief Financial Officer
Office +46 8 658 0213
Emmett Harrison
Senior Vice President Corporate Communications and Sustainability
Office +46 8 658 0173
Richard Flaherty
President US Division, US Investor Relations contact
Office +1 804 787 5130
Press spacebar to pause and continue. Press esc to stop.